These complementary pathways create synergy when combined
Research (mostly in animal models, its important to state) has shown it can help heal ulcers, repair intestinal damage from NSAIDs, and manage conditions like inflammatory bowel disease (IBD)
Although AOMs are generally not covered by Medicare, CMS has recently allowed Wegovy for patients that have both cardiovascular disease and obesitysuggesting potential future growth in this space
Patients with excess weight but not obesity might still meet the criteria if they have a related medical issue
The glucagon component drives liver-fat reduction, and the real prize here is MASH, where the LIVERAGE program is still running
If an injury is infected, the infection must be treated first